Levocetirizine & Ambroxol Hydrochloride Sustained Release Tablets 5mg+75mg Technical Specification:
| Product Name: | Levocetirizine & Ambroxol Hydrochloride Sustained Release Tablets 5mg+75mg |
| Brand Name: | Generics |
| Strength: | (5mg+75mg) |
| Dosage Form: | Tablet (Film-coated) |
| Route of Administration: | Via oral Route |
| Packing: | 10s, 30s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antiallergic |
| Indication: | Levocetirizine and ambroxol relieve cough. Levocetirizine is an antiallergic that treats runny nose, watery eyes and sneezing. Ambroxol is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out. |
| Storage: | Store in a cool, dark & dry place. Protect from direct light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Levocetirizine & Ambroxol Hydrochloride SR Tablets 5mg+75mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Levocetirizine & Ambroxol Hydrochloride SR Tablets 5mg+75mg
Each Film-coated Tablet contains:
Levocetirizine Hydrochloride IP………………5mg
Ambroxol Hydrochloride IP……………………75mg
(As Sustained Release Tablet Form)
Excipients…………………………q.s.
Colours: Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
Levocetirizine + Ambroxol is a combination of two medicines: Levocetirizine and ambroxol which relieve cough. Levocetirizine is an antiallergic that treats runny nose, watery eyes, and sneezing. Ambroxol is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Storage: Store in a cool, dark & dry place. Protect from direct light.
Dosage: As directed by the Physician.
GENERIC NAME OF THE MEDICINAL PRODUCT:
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each Film-coated Tablet contains:
Levocetirizine Hydrochloride IP………………5mg
Ambroxol Hydrochloride IP……………………75mg
(As Sustained Release Tablet Form)
Excipients…………………………q.s.
Colours: Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Dosage: As directed by the Physician.

